English

Biohit Oyj - Managers' Transactions

Report this content

Biohit Oyj Stock Exchange Release, December 5, 2016 at 5:45 pm local time (EET)

____________________________________________  

Person subject to the notification requirement

Name: Nordström, Niklas

Position: Chief Financial Officer

Issuer: Biohit Oyj

LEI: 74370089ATTSNBXJVT29  

Notification type: INITIAL NOTIFICATION

Reference number: 74370089ATTSNBXJVT29_20161205161759_3

____________________________________________  

Transaction date: 2016-12-05

Venue: NASDAQ HELSINKI LTD (XHEL)

Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT

ISIN: FI4000219324

Nature of the transaction: ACCEPTANCE OF A STOCK OPTION

(X) Linked to stock option programme    

Transaction Details (1): Volume: 30000 Unit price:  N/A EUR  

Aggregated transactions (1): Volume: 30000 Volume weighted average price:  N/A EUR

 

Additional information: 
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com


Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Subscribe